首页> 外国专利> CACHEXIA-IMPROVING REMIDY

CACHEXIA-IMPROVING REMIDY

机译:改善墨西哥州的补救措施

摘要

PURPOSE:To provide the subject remedy capable of decomposing triglycerides contained in ultralow density lipoprotein is blood and chylomicron to metabolize neutral fats to be stored, by containing a specific pyrimidine derivative (salt) as an active ingrediate. CONSTITUTION:The objective tready contains as an active ingredient a pyrimidine (salt) of formula I [Y is formula II or III (R2 is H or halogen); R1 is H, lower alkyl or aryl; R3 is lower alkyl or cyloalkyl; R4 is H, lower alkyl, OH or halogen (but when Y is formula III and the dotted line exhibits a double band); R5 is H, lower alkyl, OH, oxo or halogen (but when Y is formula III and the dotted line exhibits a double bond); R6 is H, alkyl, alkenyl, alkynyl, cycloalkyl, aryl or aralkyl; the dotted line is a single bond or double band]. The pyrimidine of formula I is usually administered in a dose of 10-1000mg/day orally and in a dose of 10-500mg/time parenterally.
机译:目的:通过提供特定的嘧啶衍生物(盐)作为活性成分,为提供能够分解超低密度脂蛋白中所含甘油三酸酯的血液和乳糜微粒,以代谢待储存的中性脂肪,以提供一种能够使本药分解的方法。组成:目标胎面含有式I [Y为式II或III(R 2为H或卤素)的嘧啶(盐)作为活性成分。 R 1为H,低级烷基或芳基; R 3为低级烷基或环烷基; R 4为H,低级烷基,OH或卤素(但当Y为式III且虚线显示双带时); R 5为H,低级烷基,OH,氧代或卤素(但当Y为式III且虚线表示双键时); R 6为H,烷基,烯基,炔基,环烷基,芳基或芳烷基;虚线是单键或双带]。式I的嘧啶通常以10-1000mg /天的剂量经口和以10-500mg /次的剂量经肠胃外给药。

著录项

  • 公开/公告号JPH0276880A

    专利类型

  • 公开/公告日1990-03-16

    原文格式PDF

  • 申请/专利权人 SANKYO CO LTD;

    申请/专利号JP19890149578

  • 申请日1989-06-14

  • 分类号A61K31/505;A61K31/535;A61P1/00;A61P1/14;A61P7/06;C07D487/14;

  • 国家 JP

  • 入库时间 2022-08-22 06:22:41

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号